Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Re size of team.
Lots of non necessary job titles there.
Liz Theakston
CUSTOMER SUCCESS MANAGER
Wtf is one of these?
Needs a really good clear out from the top down before any more funding.
40p price target with a highly dilutive placing with warrants to follow.
The market is punishing weak BOD's and this is a fat and bloated BOD with zero direction!
I wonder what happened here, no news since.
These pilots, which will initially run until 31 March 2024, will build on Feedback's pilot contract for the Sussex ICS with QVH and aim to further demonstrate the impact of a pathway approach on CDC utilisation and wider patient wait times. The pilot implementations will also facilitate GP Direct access into CDC diagnostic services.
Two pilot sites are participating in the programme - Amersham CDC in Buckinghamshire and a pan regional pilot across Buckinghamshire, Oxfordshire and Berkshire ICS (BOB ICS), looking at multiple service lines and mutual aid delivery models for sharing workforce capacity at a regional basis through the Bleepa platform.
"We would love to run a pilot". Not another one!
Yes coffee Tom is def not a salesman. Too soft. A pushover. You can see that by the lack of material contracts. The product has not needed to be trialled for over TWO years to prove its worth. Given a lot to the NHS and got sweet FA back. I would say just walk away and focus elsewhere it’s not like they’re losing much financially!
The problem is Tom has slowly replaced the old executive team with incompetent people like himself. No one to challange him.
The size of the team is ridiculous. https://fbkmed.com/about-us/team/
Because of that we've trippled our annual loss since Tom took over.
Would Nick replace Tom?
The product is built, Tom is no longer required at this binary stage of the game.
He had a long slog of a chance and achieved zero.
Time for him to go.
They need a sales Director in charge!
Nick Mayhew, Sales and Marketing Director, explores how Bleepa and CareLocker can help improve performance on faster diagnosis for cancer services.
https://bleepa.com/meeting-the-standard-on-cancer-care
Agreed PR. Both Tom and Anish massively raised expectations. Promise Jam tomorrow too many times and people will cease to believe you.
But hey you’ve got your big fat Salary eh Tom?
Agree PR, it's very poor form. If Tom is relying on some share options then he's in trouble today. Zero liquidity here.
They keep being let down by a ridiculously inefficient NHS .But they have also failed to keep PIs in the picture and I find that very hard to forgive now.They raised expectations of hearing news in the short term (AGAIN)on all fronts ,and have not explained why we havent heard anything as yet -EVEN A SIMPLE TWEET WOULD DO . Not good enough ,and the share price suffers. Very disappointing....
A company that has reliably disappointed for years. I once invested and exited within a year thankfully.
All I'd say is if this is your only stock holding and loosing the funds would hurt you then sell half and hold some cash.
Tom's heart isn't in this, it's just a job, and one hes treading water at.
They will place again, once that placings churned over and the price slipped I'll have a look at reentry.
Don't fall in love with paying their salaries.
This share has become an absolute joke, run by Muppets. False promises with smoke and mirror statements. Gl.
Game over if there's another placing. So many opportunities right now, if they can't convert, especially QVH, then they need to sell up.
There is already a strong precedent on AIM of directors not owning a single share in their company that they so passionately want you to buy shares in. They use your funds, placing after placing to prove up the business and then bankrupt it with extortionate salaries and fees for "advisors" (mates). Then they buy the business back from the adminstrators for peanuts and become 100% shareholders.
BIDS & KOOVS are just some examples of this strategy.
I won't be investing until Tom & co put their cash in FDBK.
FDBK is running out of money fast and they failed to pump the price in March suffciently to a get placing done. That's your warning sign.
Maybe a retest at 45p.
Depends on news, cash position etc.
Tom's being quiet and he has done that previously ...
Sea view,
Possibly under 60 as lots more shares in issue now.
Sitting looking at potential re - entry but that depends on direction, with Tom in charge its a trade only position imo.
I think its time for a new CEO, they need to put a businessman in to push sales and look at numbers not if, when and maybe's.
I love the tech here, think its superb, the management and wider NHS customer base much less so, needs some drive and aggression to pump it forward and maybe politicise its ability to become widely adopted.
If they don't get their finger out very soon someone else will do it quicker, brighter and cheaper.
Maybe...
I fancy another bite @85p, but no news on contracts may cause drift to new low sub 60p
....and then, sometime, another fun spike for the nth time
No news & drifting. Back to 60?
I found this paragraph in the Capital Planning Update section of the Council of Governors Meeting in public
Monday 22 April 2024
"We will also have two centrally funded programmes in this new financial year – our
Community Diagnostic Centre (CDC) new build £6.7m and the Electronic Patient
Record programme (EPR) £3.9m. "
it would be helpful to find a breakdown on how the £6.7 new build money will be allocated.
https://www.qvh.nhs.uk/wp-content/uploads/2024/04/Papers-PUBLIC-CoG-meeting-22-April-2024.pdf
Nm
Next meeting is the 2nd May.
Thinking about it I suppose the delay in awarding the contract may indicate it is going to be feedback ,as the nearer they go to the 30 june the less time a new contractor would have to pick up the baton .
But given what happened last time (and there was no mention of a legal challenge at the time- only recently)it would ne nice to get some kind of comforting tweet from Tom to the effect the contract has not yet been notified but the process is still on track .Maybe there is a board meeting due and that's when it'll be confirmed? who normally posts the board papers please?
You're probably right. It was their sunrise air app that wouldn't need a lot of tweaking. Tom bangs on about bleepa being the only fully certified image transfer/sharing app, that ain't gonna be the case for ever.
I don’t agree IB. I don’t see any particular overlap at all with Bleepa. Bleepa is for clinicians use primarily to view clinical images and form a clinical pathway. Altera is purely a digital administrative system for patient records. If you are inferring they did not not select CareLocker to hold patient records I don’t think it was ever suggested that was part of the contract with QVH. Nothing to worry about there. :)